ProFound AI for Digital Breast Tomosynthesis

JSON twin: https://www.healthaidb.com/software/profound-ai-for-digital-breast-tomosynthesis.json

Company Name

iCAD

Product URL

https://www.icadmed.com/products/profound-ai-for-digital-breast-tomosynthesis

Company URL

https://www.icadmed.com

Categories

• diagnostic Support
• clinical Care
• administrative Operations
• Diagnostic
• Clinical
• Administrative

Summary

ProFound AI for Digital Breast Tomosynthesis is an AI-driven software developed by iCAD to enhance breast cancer detection in 3D mammography images, improving accuracy and efficiency for radiologists.

Description

ProFound AI for Digital Breast Tomosynthesis is an advanced artificial intelligence solution designed to assist radiologists in interpreting 3D mammography images. It rapidly analyzes each tomosynthesis image, detecting malignant soft tissue densities and calcifications with high accuracy. The software provides lesion and case scores, aiding in clinical decision-making and workflow optimization. Clinically proven benefits include an average 8% increase in sensitivity, a 7.2% reduction in unnecessary patient recalls, and a 52.7% reduction in reading time. ProFound AI is compatible with leading digital breast tomosynthesis systems and has received FDA clearance and CE Mark certification. It is available in various regions, including the United States and Europe, and supports multiple languages. The pricing model is subscription-based, with details available upon request. The company, iCAD, was founded in 2004 and has offices in the United States and Europe.

Api Available

yes

Certifications

• FDA 510(k) clearance
• CE Mark (Class IIa, MDD)

Company Founding

2004

Company Offices

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Canada
• Australia
• Japan
• South Korea

Compliance

• HIPAA
• GDPR

Customers

Data Residency

US and EU regions

Data Standards

• DICOM
• IHE
• HL7

Deployment Model

• on_premises
• cloud

Features

• Concurrent-read cancer detection for Digital Breast Tomosynthesis (DBT)
• Automated lesion detection and marking (soft tissue densities and calcifications)
• Case and lesion-level scoring (ProFound Scorecard)
• Automated breast density assessment
• Short-term (1-2 year) personalized risk scoring (ProFound Risk)
• Worklist prioritization and color-coded triage
• Support for prior/comparative exams
• Reduction in reading time / workflow acceleration
• Fewer marks per 3D view to reduce distraction
• Breast arterial calcification (BAC) assessment (research module)
• Multi-vendor OEM compatibility (2D & 3D)
• Integration-ready (PACS/RIS/VNA) workflow hooks
• Automated case summary for reporting
• Score-based lesion visualization

Id

SW0696

Integration Partners

Integrations

• PACS (50+ PACS vendors supported)
• RamSoft
• Sectra
• VNA
• RIS
• OEM mammography vendors (2D & DBT manufacturers)
• AI platform/workflow providers

Languages Supported

• English
• Spanish
• French
• German
• Italian
• Portuguese
• Dutch
• Swedish
• Norwegian
• Danish
• Finnish
• Russian
• Chinese
• Japanese
• Korean
• Arabic
• Hebrew
• Turkish
• Hindi
• Bengali

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb

Optional Modules

• Breast arterial calcification (BAC) assessment (research module)

Os Platforms

• Windows
• Linux

Pricing Details

Contact vendor for pricing information.

Pricing Model

subscription

Privacy Features

• BAA available
• Consent management
• Anonymization
• Data minimization

Product Code

SW0696

Product Name

ProFound AI for Digital Breast Tomosynthesis

Ratings

Regions Available

• United States
• Europe
• Canada
• Australia
• New Zealand
• Japan
• South Korea
• China
• India
• Brazil
• Mexico
• Argentina
• Chile
• Colombia
• Peru
• South Africa
• Egypt
• Saudi Arabia
• United Arab Emirates
• Israel

Related Urls

• https://healthairegister.com/radiology/products/icad-profound-ai-for-digital-breast-tomosynthesis

Release Year

Security Features

• Encryption in transit and at rest
• Role-based access control (RBAC)
• SSO/SAML support
• Audit logging

Specialties

• Breast Imaging
• Radiology

Support Channels

System Requirements

Dedicated hardware for on-premises deployment; cloud-based infrastructure for cloud deployment

Target Users

• radiologists
• clinicians
• medical imaging centers

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "ProFound AI for Digital Breast Tomosynthesis",
  "company_name": "iCAD",
  "product_url": "https://www.icadmed.com/products/profound-ai-for-digital-breast-tomosynthesis",
  "company_url": "https://www.icadmed.com",
  "related_urls": [
    "https://healthairegister.com/radiology/products/icad-profound-ai-for-digital-breast-tomosynthesis"
  ],
  "product_code": "SW0696",
  "summary": "ProFound AI for Digital Breast Tomosynthesis is an AI-driven software developed by iCAD to enhance breast cancer detection in 3D mammography images, improving accuracy and efficiency for radiologists.",
  "description": "ProFound AI for Digital Breast Tomosynthesis is an advanced artificial intelligence solution designed to assist radiologists in interpreting 3D mammography images. It rapidly analyzes each tomosynthesis image, detecting malignant soft tissue densities and calcifications with high accuracy. The software provides lesion and case scores, aiding in clinical decision-making and workflow optimization. Clinically proven benefits include an average 8% increase in sensitivity, a 7.2% reduction in unnecessary patient recalls, and a 52.7% reduction in reading time. ProFound AI is compatible with leading digital breast tomosynthesis systems and has received FDA clearance and CE Mark certification. It is available in various regions, including the United States and Europe, and supports multiple languages. The pricing model is subscription-based, with details available upon request. The company, iCAD, was founded in 2004 and has offices in the United States and Europe.",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "administrative Operations",
    "Diagnostic",
    "Clinical",
    "Administrative"
  ],
  "market_segment": [
    "enterprise",
    "smb"
  ],
  "target_users": [
    "radiologists",
    "clinicians",
    "medical imaging centers"
  ],
  "specialties": [
    "Breast Imaging",
    "Radiology"
  ],
  "regions_available": [
    "United States",
    "Europe",
    "Canada",
    "Australia",
    "New Zealand",
    "Japan",
    "South Korea",
    "China",
    "India",
    "Brazil",
    "Mexico",
    "Argentina",
    "Chile",
    "Colombia",
    "Peru",
    "South Africa",
    "Egypt",
    "Saudi Arabia",
    "United Arab Emirates",
    "Israel"
  ],
  "languages_supported": [
    "English",
    "Spanish",
    "French",
    "German",
    "Italian",
    "Portuguese",
    "Dutch",
    "Swedish",
    "Norwegian",
    "Danish",
    "Finnish",
    "Russian",
    "Chinese",
    "Japanese",
    "Korean",
    "Arabic",
    "Hebrew",
    "Turkish",
    "Hindi",
    "Bengali"
  ],
  "pricing_model": "subscription",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "commercial",
  "company_offices": [
    "United States",
    "Germany",
    "France",
    "United Kingdom",
    "Italy",
    "Spain",
    "Canada",
    "Australia",
    "Japan",
    "South Korea"
  ],
  "company_founding": "2004",
  "deployment_model": [
    "on_premises",
    "cloud"
  ],
  "os_platforms": [
    "Windows",
    "Linux"
  ],
  "features": [
    "Concurrent-read cancer detection for Digital Breast Tomosynthesis (DBT)",
    "Automated lesion detection and marking (soft tissue densities and calcifications)",
    "Case and lesion-level scoring (ProFound Scorecard)",
    "Automated breast density assessment",
    "Short-term (1-2 year) personalized risk scoring (ProFound Risk)",
    "Worklist prioritization and color-coded triage",
    "Support for prior/comparative exams",
    "Reduction in reading time / workflow acceleration",
    "Fewer marks per 3D view to reduce distraction",
    "Breast arterial calcification (BAC) assessment (research module)",
    "Multi-vendor OEM compatibility (2D & 3D)",
    "Integration-ready (PACS/RIS/VNA) workflow hooks",
    "Automated case summary for reporting",
    "Score-based lesion visualization"
  ],
  "optional_modules": [
    "Breast arterial calcification (BAC) assessment (research module)"
  ],
  "integrations": [
    "PACS (50+ PACS vendors supported)",
    "RamSoft",
    "Sectra",
    "VNA",
    "RIS",
    "OEM mammography vendors (2D & DBT manufacturers)",
    "AI platform/workflow providers"
  ],
  "data_standards": [
    "DICOM",
    "IHE",
    "HL7"
  ],
  "api_available": "yes",
  "system_requirements": "Dedicated hardware for on-premises deployment; cloud-based infrastructure for cloud deployment",
  "compliance": [
    "HIPAA",
    "GDPR"
  ],
  "certifications": [
    "FDA 510(k) clearance",
    "CE Mark (Class IIa, MDD)"
  ],
  "security_features": [
    "Encryption in transit and at rest",
    "Role-based access control (RBAC)",
    "SSO/SAML support",
    "Audit logging"
  ],
  "privacy_features": [
    "BAA available",
    "Consent management",
    "Anonymization",
    "Data minimization"
  ],
  "data_residency": "US and EU regions",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0696",
  "slug": "profound-ai-for-digital-breast-tomosynthesis",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/profound-ai-for-digital-breast-tomosynthesis.json"
  }
}